| Year |
Citation |
Score |
| 2021 |
Assumpção ALFV, Fu G, Singh DK, Lu Z, Kuehnl AM, Welch R, Ong IM, Wen R, Pan X. A lineage-specific requirement for YY1 polycomb group protein function in early T cell development. Development (Cambridge, England). PMID 33766932 DOI: 10.1242/dev.197319 |
0.343 |
|
| 2019 |
Wood EA, Lu Z, Jia S, Assumpção ALFV, Van Hesteren MA, Huelsmeyer MK, Vail DM, Pan X. Pevonedistat targeted therapy inhibits canine melanoma cell growth through induction of DNA re-replication and senescence. Veterinary and Comparative Oncology. PMID 31665821 DOI: 10.1111/Vco.12546 |
0.375 |
|
| 2018 |
Assumpção ALFV, Lu Z, Marlowe KW, Shaffer KS, Pan X. Targeting NEDD8-activating enzyme is a new approach to treat canine diffuse large B-cell lymphoma. Veterinary and Comparative Oncology. PMID 30101447 DOI: 10.1111/Vco.12428 |
0.389 |
|
| 2018 |
Lu Z, Hong CC, Kong G, Assumpção ALFV, Ong IM, Bresnick EH, Zhang J, Pan X. Polycomb Group Protein YY1 Is an Essential Regulator of Hematopoietic Stem Cell Quiescence. Cell Reports. 22: 1545-1559. PMID 29425509 DOI: 10.1016/J.Celrep.2018.01.026 |
0.468 |
|
| 2018 |
Lu Z, Assumpção ALFV, Viny AD, Levine RL, Pan X. YY1 Controls Hematopoietic Stem Cell Quiescence By Repressing Cohesin Expression Blood. 132: 3831-3831. DOI: 10.1182/Blood-2018-99-118679 |
0.366 |
|
| 2017 |
Assumpção ALFV, Jark PC, Hong CC, Lu Z, Ruetten HM, Heaton CM, Pinkerton ME, Pan X. STAT3 Expression and Activity are Up-Regulated in Diffuse Large B Cell Lymphoma of Dogs. Journal of Veterinary Internal Medicine. PMID 29119628 DOI: 10.1111/Jvim.14860 |
0.352 |
|
| 2017 |
Lu Z, Hong CC, Jark PC, Assumpção ALFV, Bollig N, Kong G, Pan X. JAK1/2 Inhibitors AZD1480 and CYT387 Inhibit Canine B-Cell Lymphoma Growth by Increasing Apoptosis and Disrupting Cell Proliferation. Journal of Veterinary Internal Medicine. PMID 28960447 DOI: 10.1111/Jvim.14837 |
0.382 |
|
| 2016 |
Pan X, Hong C, Kong G. Polycomb group protein Yin Yang 1 controls quiescence and self-renewal potential in hematopoietic stem cells Experimental Hematology. 44. DOI: 10.1016/J.Exphem.2016.06.202 |
0.322 |
|
| 2013 |
Pan X, Papasani M, Hao Y, Calamito M, Wei F, Quinn Iii WJ, Basu A, Wang J, Hodawadekar S, Zaprazna K, Liu H, Shi Y, Allman D, Cancro M, Atchison ML. YY1 controls Igκ repertoire and B-cell development, and localizes with condensin on the Igκ locus. The Embo Journal. 32: 1168-82. PMID 23531880 DOI: 10.1038/Emboj.2013.66 |
0.579 |
|
| 2012 |
Pan X, Jones M, Jiang J, Zaprazna K, Yu D, Pear W, Maillard I, Atchison ML. Increased expression of PcG protein YY1 negatively regulates B cell development while allowing accumulation of myeloid cells and LT-HSC cells. Plos One. 7: e30656. PMID 22292011 DOI: 10.1371/Journal.Pone.0030656 |
0.595 |
|
| 2010 |
Basu A, Hodawadekar S, Andrews O, Knox A, Pan X, Wilkinson F, Atchison ML. YY1 PcG function as a Potential cancer Therapeutic Target Forum On Immunopathological Diseases and Therapeutics. 1: 31-50. DOI: 10.1615/Forumimmundisther.V1.I1-2.30 |
0.508 |
|
| 2005 |
Srinivasan L, Pan X, Atchison ML. Transient requirements of YY1 expression for PcG transcriptional repression and phenotypic rescue. Journal of Cellular Biochemistry. 96: 689-99. PMID 16052488 DOI: 10.1002/Jcb.20562 |
0.537 |
|
| Show low-probability matches. |